Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.

Journal Information

Full Title: J Neuroimmunol

Abbreviation: J Neuroimmunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest IN is serving on scientific advisory boards for Biogen Japan and Novartis Pharma and is receiving honoraria for speaking engagements with Biogen Japan, Mitsubishi Tanabe Pharma, Novartis Pharma, Takeda Pharmaceutical, and Eisai. IN is receiving research support from 10.13039/100009539LSI Medience and is funded by 10.13039/501100003478MHLW Program Grant Number 20FC1030 and JSPS KAKENHI Grant Number 20K07892. JF and KM report no disclosures."

Evidence found in paper:

"10.13039/100009539LSI; 10.13039/501100003478MHLW; JSPS KAKENHI"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025